Engin Ozkan to Rituximab
This is a "connection" page, showing publications Engin Ozkan has written about Rituximab.
Connection Strength
0.027
-
Engineered SIRPa variants as immunotherapeutic adjuvants to anticancer antibodies. Science. 2013 Jul 05; 341(6141):88-91.
Score: 0.027
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.